ESTRO37_ProgrammeBook

10:40 > Randomized controlled trial of Cone Beam CT IGRT in prostate cancer H. Tøndel (Norway), J. Lund, S. Lydersen, A. Wanderås, B. Aksnessæther, C. Jensen, S. Kaasa, A. Solberg 10:50 > Relating dose outside the prostate with freedom from failure in the Dutch HYPRO trial M. Witte (The Netherlands), F. Pos, L. Incrocci, W. Heemsbergen 11:00 > Testosterone recovery following androgen deprivation and radiation therapy for prostate cancer D. Spiegel (USA), J. Hong, T. Oyekunle, W. Lee, J. Salama, B. Koontz 11:10 > Weekly vs. every-other-day prostate cancer SBRT: 18-months results from a randomized phase II trial T. Zilli (Switzerland), S. Jorcano, S. Bral, C. Rubio, A. Bruynzeel, A. Oliveira, U. Abacioglu, H. Minn, Z. Symon, R. Miralbell 11:20 > 5-year efficacy and quality of life outcomes of a multi-institutional HDR-Like prostate SBRT trial D. Fuller (USA), B. Kane, C. Medbery, K. Underhill, J. Gray, A. Peddada, R. Chen 11:30 > Interim results of a randomized trial of observation versus SABR for oligometastatic prostate cancer

OC-0500

MONDAY 23 APRIL 2018

OC-0501

OC-0502

OC-0503

OC-0504

P. Tran (USA), N. Radwan, R. Phillips, A. Ross, S. Rowe, M. Gorin, E. Antonarakis, C. DeVille, S. Greco, S. Denmeade, C. Paller, D. Song, M. Diehn, H. Wang, M. Carducci, K. Pienta, M. Pomper, T. DeWeese, A. Dicker, M. Eisenberger

 OC-0505

PROFFERED PAPER PH 9: Analysis of treatment outcomes 10:30 - 11:45  |  ROOM 112 Chair: M. Thor (USA) Chair: W. Heemsbergen (The Netherlands)

10:30 > A model of tumour response to radiation considering 3D vascular architectures and vascular damage A. Gago-Arias (Chile), I. Espinoza, P. Franco 10:40 > The effect of incidental dose on out-of-field failure probability in anal cancer M. Van Herk (United Kingdom), H. Sekhar, E. Vasquez Osorio, T. Marchant, R. Kochhar, A. Renehan

OC-0506

OC-0507

SCIENTIFIC PROGRAMME | Programme and Exhibition Guide

152